InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
0.00%
)
US TECH 100
17,688.40
(
-0.20%
)
Dow Jones
39,431.51
(
0.00%
)
Brent Oil
82.59
(
-0.75%
)
Bitcoin
61,443.75
(
-2.32%
)
Post# of 869
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Raffis

Send PM Follow Ignore
Followers 11
Posts 1237
Boards Moderated 0
Alias Born 03/03/2019

Raffis

Re: None

Monday, 02/01/2021 1:43:18 PM

Monday, February 01, 2021 1:43:18 PM

Post# of 869
MAT9001 & Vascepa are studied “as adjuncts to statins.” They we’re not administered alone. MAT9001 blew VASCEPA away - - “as an adjunct to statin therapy.” Therefore MAT9001 has higher efficacy than VASCEPA alone and with Statins. VASCEPA is weaker and less effective.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MTNB News
More MTNB News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Start posting your company's news
Only $200 per official company press release!